first of all, don't get reactive and all emotional. $15m was the new clinical trial(that spectrum is now funding) investment needed by Allergan to continue with the original agreement, where they retained the rights in US, EU and other major territory ...they didnt want to invest $15m and they settled to get less than 5% royalty on sales.
Most importantly, please provide ALL CITES for your authority and to support your assertions. Your own views are completely irrelevant at this point. You have completely undermined your own veracity and integrity.